The European Molecular Organization (EMBO) and Nature Publishing Group (NPG) are pleased to announce that The EMBO Journal and EMBO reports will accept open-access articles as of January 2007, subject to payment of a publication fee.

The journals are moving to a mixed-revenue model of subscription charges and publication fees. The open-access option will be available to all authors submitting original research on or after 1 January 2007. The publication fee will be €2,000 plus VAT (where applicable). Articles published with a publication fee will be clearly identified in the online and print editions of the journal with an open-access icon. Print subscription prices will not be affected and site license prices will be adjusted in line with the amount of subscription content published annually.

The journal editors will be blind to the author's choice, avoiding any possibility of a conflict of interest during and acceptance. Authors paying the publication fee will be entitled to self-archive the published version immediately on publication in a repository of their choice, and in any format. Content that an author has decided to make freely available online will be licensed under the Creative Commons Deed 2.5 (http://creativecommons.org/licenses/by-nc-nd/2.5/). The author thereby permits dissemination and re-use of the article, enabling the sharing and re-use of scientific material. This does not however permit commercial exploitation or the creation of derivative works without specific permission.

Other articles will continue to be published under NPG’s exclusive License-to-Publish, where its usual self-archiving policy will apply. Original research published in Molecular Systems Biology, the open-access journal co-owned by EMBO and NPG will also be offered under the Creative Commons Deed 2.5 as of January 2007.

The EMBO Journal and EMBO reports are published by NPG on behalf of EMBO. NPG publishes the open-access title Molecular Systems Biology in partnership with EMBO, and subscription journals such as Nature and Nature Cell Biology, as well as other society-owned titles such as Kidney International and Journal of Investigative Dermatology.